# Carboplatin

## Paraplatin inj 150mg/15mL

| TAH Drug Code      | [**IPAR**](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IPAR)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Ovarian cancer, advanced: Initial treatment of advanced ovarian cancer in combination with other established chemotherapy agents; palliative treatment of recurrent ovarian cancer after prior chemotherapy, including cisplatin-based treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Dosing             | CALVERT FORMULA FOR CARBOPLATIN DOSING: Total Dose (mg) = (target AUC mg/mL‧min)) x (GFR mL/min + 25)Target AUC of 4-6 mg/mL‧min using single-agent carboplatin appears to provide the most appropriate dose range in previously treated patients.  [Recurrent Ovarian Carcinoma] 360 mg/m2 as a single agent on day 1 every 4 weeks. Treatment course should not be repeated until the neutrophil count is > 2,000 and the platelet count is > 100,000.  [Advanced Ovarian Cancer, previously untreated] 300 mg/m2 in combination with cyclophosphamide 600 mg/m2 on day 1 every 4 weeks for 6 cycles. Treatment course should not be repeated until the neutrophil count is > 2,000 and the platelet count is > 100,000. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Contraindications  | History of severe allergic reaction to carboplatin, cisplatin, other platinum-containing formulations, mannitol, or any component of the formulation; should not be used in patients with severe bone marrow depression or significant bleeding.                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Adverse Effects    | Myelosuppression especially thrombocytopenia, leukopenia; nausea & vomiting, abdominal pain, diarrhea, constipation; nephrotoxicity; neurotoxicity including paresthesia & decreased deep tendon reflexes; transient visual disturbances, ototoxicity manifesting as tinnitus; abnormal liver function tests; hypersensitivity reactions.                                                                                                                                                                                                                                                                                                                                                                                  |
| Pregnancy          | Contraindicated – 1st Trimester                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Lactation          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |

